Literature DB >> 33770213

Staphylococcus aureus Potentiates the Hemolytic Activity of Burkholderia cepacia Complex (Bcc) Bacteria.

Alessandro Moriano1, Diego O Serra2, Amparo Hoard1, Sabrina Montaña3, Jose Degrossi4,5, Robert A Bonomo6,7,8, Krisztina M Papp-Wallace6,7,8, Maria Soledad Ramirez9.   

Abstract

Polymicrobial lung infections in individuals with Cystic Fibrosis (CF) contribute to the complexity of this disease and are a major cause of morbidity and mortality in the CF community. The microorganisms most commonly associated with severe airway infections in individuals with CF are the opportunistic pathogens S. aureus, P. aeruginosa and bacteria from the Burkholderia cepacia complex (Bcc), particularly B. cenocepacia and B. multivorans. Three Bcc strains, two S. aureus wild-type strains, and two derivative mutants were used to investigate the interplay between S. aureus and Bcc with a focus on the hemolytic activity of Bcc. Our results revealed that extracellular products from S. aureus potentiated the hemolysis of Bcc strains. Moreover, this effect was influenced by the composition of the medium in which S. aureus is grown. These findings contribute towards the understanding of the impact of interactions between S. aureus and Bcc and their possible implications in the context of co-infections by these pathogens in individuals with CF.

Entities:  

Mesh:

Year:  2021        PMID: 33770213     DOI: 10.1007/s00284-021-02458-0

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  14 in total

1.  Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.

Authors:  E Vanderhelst; L De Meirleir; S Verbanck; D Piérard; W Vincken; A Malfroot
Journal:  J Cyst Fibros       Date:  2011-09-09       Impact factor: 5.482

2.  Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis.

Authors:  Elliott C Dasenbrook; William Checkley; Christian A Merlo; Michael W Konstan; Noah Lechtzin; Michael P Boyle
Journal:  JAMA       Date:  2010-06-16       Impact factor: 56.272

3.  The cystic fibrosis lung microbiome.

Authors:  Michael G Surette
Journal:  Ann Am Thorac Soc       Date:  2014-01

4.  Microbial Interactions in the Cystic Fibrosis Airway.

Authors:  Ann M Granchelli; Frederick R Adler; Ruth H Keogh; Christiana Kartsonaki; David R Cox; Theodore G Liou
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

Review 5.  Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.

Authors:  John R W Govan; Alan R Brown; Andrew M Jones
Journal:  Future Microbiol       Date:  2007-04       Impact factor: 3.165

Review 6.  Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.

Authors:  James F Chmiel; Timothy R Aksamit; Sanjay H Chotirmall; Elliott C Dasenbrook; J Stuart Elborn; John J LiPuma; Sarath C Ranganathan; Valerie J Waters; Felix A Ratjen
Journal:  Ann Am Thorac Soc       Date:  2014-09

7.  Staphylococcus aureus products subvert the Burkholderia cenocepacia-induced inflammatory response in airway epithelial cells.

Authors:  Yuan Ji; Albert Bolhuis; Malcolm L Watson
Journal:  J Med Microbiol       Date:  2019-12       Impact factor: 2.472

8.  Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.

Authors:  Marij J Welters; Tetje C van der Sluis; Hélène van Meir; Nikki M Loof; Vanessa J van Ham; Suzanne van Duikeren; Saskia J Santegoets; Ramon Arens; Marieke L de Kam; Adam F Cohen; Mariette I van Poelgeest; Gemma G Kenter; Judith R Kroep; Jacobus Burggraaf; Cornelis J Melief; Sjoerd H van der Burg
Journal:  Sci Transl Med       Date:  2016-04-13       Impact factor: 17.956

9.  A Burkholderia cepacia complex non-ribosomal peptide-synthesized toxin is hemolytic and required for full virulence.

Authors:  Euan L S Thomson; Jonathan J Dennis
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

Review 10.  In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp.

Authors:  An Hotterbeekx; Samir Kumar-Singh; Herman Goossens; Surbhi Malhotra-Kumar
Journal:  Front Cell Infect Microbiol       Date:  2017-04-03       Impact factor: 5.293

View more
  1 in total

1.  Staphylococcus aureus α-Toxin Effect on Acinetobacter baumannii Behavior.

Authors:  Jennifer S Fernandez; Marisel R Tuttobene; Sabrina Montaña; Tomás Subils; Virginia Cantera; Andrés Iriarte; Lorena Tuchscherr; Maria Soledad Ramirez
Journal:  Biology (Basel)       Date:  2022-04-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.